Work

127 (PB115): Survival benefit and tumor regression with a dual RAS/β-catenin inhibitor, ADT-030, in murine models of pancreatic and lung cancer

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114650

Authors: D.S.R. Bandi, G.P. Nagaraju, J.B. Foote, A. Keeton, X. Chen, K.L. Berry, Y.Y. Maxuitenko, U. Manne, D.J. Buchsbaum, G.A. Piazza, B.F. El-Rayes

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403763667

FWCI:

Cites:

Cited by:

Related to: 10